Nesri Padayatchi
About
Nesri Padayatchi is a scholar working on Infectious Diseases, Epidemiology and Surgery.
According to data from OpenAlex, Nesri Padayatchi has authored 131 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 116 papers in Infectious Diseases, 84 papers in Epidemiology and 22 papers in Surgery. Recurrent topics in Nesri Padayatchi's work include Tuberculosis Research and Epidemiology (96 papers), Pneumocystis jirovecii pneumonia detection and treatment (52 papers) and HIV/AIDS Research and Interventions (31 papers). Nesri Padayatchi is often cited by papers focused on Tuberculosis Research and Epidemiology (96 papers), Pneumocystis jirovecii pneumonia detection and treatment (52 papers) and HIV/AIDS Research and Interventions (31 papers). Nesri Padayatchi collaborates with scholars based in South Africa, United States and United Kingdom. Nesri Padayatchi's co-authors include Kogieleum Naidoo, Max R. O’Donnell, Amrita Daftary, Salim S. Abdool Karim, Gonasagrie Nair, Iqbal Master, Quarraisha Abdool Karim, Wafaa El‐Sadr, Navisha Dookie and Anneke Grobler and has published in prestigious journals such as New England Journal of Medicine, Nature Genetics and SHILAP Revista de lepidopterología.
In The Last Decade
Nesri Padayatchi
128 papers receiving 4.3k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Nesri Padayatchi South Africa | 37 | 3.6k | 2.7k | 1.1k | 373 | 293 | 131 | 4.4k | ||
| Kogieleum Naidoo South Africa | 31 | 3.2k 0.9× | 2.2k 0.8× | 1.0k 0.9× | 366 1.0× | 247 0.8× | 175 | 4.1k | ||
| Sayoki Mfinanga Tanzania | 30 | 2.5k 0.7× | 1.9k 0.7× | 696 0.6× | 529 1.4× | 226 0.8× | 159 | 4.2k | ||
| Marcos Espinal United States | 36 | 4.0k 1.1× | 3.1k 1.2× | 1.5k 1.3× | 430 1.2× | 147 0.5× | 75 | 5.0k | ||
| Neel R. Gandhi United States | 35 | 5.5k 1.5× | 4.4k 1.6× | 2.0k 1.7× | 696 1.9× | 225 0.8× | 125 | 6.7k | ||
| Haileyesus Getahun Switzerland | 28 | 3.8k 1.1× | 3.0k 1.1× | 1.5k 1.3× | 521 1.4× | 173 0.6× | 57 | 4.8k | ||
| Francesca Conradie South Africa | 28 | 2.8k 0.8× | 1.6k 0.6× | 619 0.6× | 366 1.0× | 284 1.0× | 91 | 3.4k | ||
| Umesh Lalloo South Africa | 33 | 2.7k 0.8× | 2.1k 0.8× | 832 0.7× | 285 0.8× | 424 1.4× | 105 | 5.7k | ||
| Mercedes C. Becerra United States | 27 | 3.1k 0.9× | 2.3k 0.8× | 1.1k 1.0× | 174 0.5× | 247 0.8× | 97 | 3.7k | ||
| Peter Mwaba Zambia | 44 | 4.4k 1.2× | 3.4k 1.3× | 1.5k 1.3× | 847 2.3× | 196 0.7× | 111 | 6.4k | ||
| Anthony P. Moll United States | 28 | 3.2k 0.9× | 2.5k 0.9× | 1.2k 1.0× | 208 0.6× | 256 0.9× | 69 | 3.7k |
Countries citing papers authored by Nesri Padayatchi
Since
Specialization
Citations
This map shows the geographic impact of Nesri Padayatchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nesri Padayatchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nesri Padayatchi more than expected).
Fields of papers citing papers by Nesri Padayatchi
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Nesri Padayatchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nesri Padayatchi. The network helps show where Nesri Padayatchi may publish in the future.
Co-authorship network of co-authors of Nesri Padayatchi
This figure shows the co-authorship network connecting the top 25 collaborators of Nesri Padayatchi. A scholar is included among the top collaborators of Nesri Padayatchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nesri Padayatchi. Nesri Padayatchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Rambaran, Santhuri, Lara Lewis, Sinaye Ngcapu, et al.. (2023). NK cell phenotypic profile during active TB in people living with HIV-evolution during TB treatment and implications for bacterial clearance and disease severity. Scientific Reports. 13(1). 11726–11726.
2.
Rambaran, Santhuri, Lara Lewis, Razia Hassan-Moosa, et al.. (2023). Blood monocyte and dendritic cell profiles among people living with HIV with Mycobacterium tuberculosis co-infection. BMC Immunology. 24(1). 21–21.
3.
Perumal, Rubeshan, Kogieleum Naidoo, Anushka Naidoo, et al.. (2022). The impact of enteral feeding and therapeutic monitoring of rifampicin with dose escalation in critically ill patients with tuberculosis. International Journal of Infectious Diseases. 126. 174–180.
4.
Dookie, Navisha, et al.. (2022). Application of Next Generation Sequencing for Diagnosis and Clinical Management of Drug-Resistant Tuberculosis: Updates on Recent Developments in the Field. Frontiers in Microbiology. 13. 775030–775030.
5.
Law, Stephanie, Olivia Oxlade, Halima Dawood, et al.. (2021). Acceptability, feasibility, and impact of a pilot tuberculosis literacy and treatment counselling intervention: a mixed methods study. BMC Infectious Diseases. 21(1). 449–449.
6.
Padayatchi, Nesri, Farzana Osman, Norbert Ndjeka, et al.. (2020). Treatment outcomes in patients with drug-resistant TB-HIV co-infection treated with bedaquiline and linezolid. The International Journal of Tuberculosis and Lung Disease. 24(10). 1024–1031.
7.
Rieder, Hans L., et al.. (2020). When to start treatment? Dilemma illustrated by a paediatric case of extensively drug-resistant tuberculosis of the central nervous system. South African Medical Journal. 110(9). 846–846.
8.
Nimmo, Camus, James Millard, Lucy van Dorp, et al.. (2020). Population-level emergence of bedaquiline and clofazimine resistance-associated variants among patients with drug-resistant tuberculosis in southern Africa: a phenotypic and phylogenetic analysis. The Lancet Microbe. 1(4). e165–e174.
9.
Zelnick, Jennifer, Amrita Daftary, K. Rivet Amico, et al.. (2018). Training social workers to enhance patient-centered care for drug-resistant TB-HIV in South Africa. Public Health Action. 8(1). 25–27.
10.
Mahomed, Sharana, Kogieleum Naidoo, Navisha Dookie, & Nesri Padayatchi. (2017). Whole genome sequencing for the management of drug-resistant TB in low income high TB burden settings: Challenges and implications. Tuberculosis. 107. 137–143.
11.
Daftary, Amrita & Nesri Padayatchi. (2016). Provider perspectives on drug-resistant tuberculosis and human immunodeficiency virus care in South Africa: a qualitative case study. The International Journal of Tuberculosis and Lung Disease. 20(11). 1483–1488.
12.
O’Donnell, Max R., Melendhran Pillay, Manormoney Pillay, et al.. (2015). Primary Capreomycin Resistance Is Common and Associated With Early Mortality in Patients With Extensively Drug-Resistant Tuberculosis in KwaZulu-Natal, South Africa. JAIDS Journal of Acquired Immune Deficiency Syndromes. 69(5). 536–543.
13.
O’Donnell, Max R., Allison Wolf, Lise Werner, C. Robert Horsburgh, & Nesri Padayatchi. (2014). Adherence in the Treatment of Patients With Extensively Drug-Resistant Tuberculosis and HIV in South Africa. JAIDS Journal of Acquired Immune Deficiency Syndromes. 67(1). 22–29.
14.
O’Donnell, Max R., Nesri Padayatchi, Charlotte Kvasnovsky, et al.. (2013). Treatment Outcomes for Extensively Drug-Resistant Tuberculosis and HIV Co-infection. Emerging infectious diseases. 19(3). 416–424.
15.
O’Donnell, Max R., Jennifer Zelnick, Lise Werner, et al.. (2011). Extensively Drug-Resistant Tuberculosis in Women, KwaZulu-Natal, South Africa. Emerging infectious diseases.
16.
O’Donnell, Max R., Jennifer Zelnick, Lise Werner, et al.. (2011). Extensively Drug-Resistant Tuberculosis in Women, KwaZulu-Natal, South Africa. Emerging infectious diseases. 17(10). 1942–1945.
17.
Brust, James C. M., et al.. (2010). High treatment failure and default rates for patients with multidrug-resistant tuberculosis in KwaZulu-Natal, South Africa, 2000-2003.. PubMed. 14(4). 413–9.
18.
Dorman, Susan E., John L. Johnson, Stefan Goldberg, et al.. (2009). Substitution of Moxifloxacin for Isoniazid during Intensive Phase Treatment of Pulmonary Tuberculosis. American Journal of Respiratory and Critical Care Medicine. 180(3). 273–280.
19.
Sirgel, F A, P. Bernard Fourie, Peter R. Donald, et al.. (2005). The Early Bactericidal Activities of Rifampin and Rifapentine in Pulmonary Tuberculosis. American Journal of Respiratory and Critical Care Medicine. 172(1). 128–135.
20.
Padayatchi, Nesri, et al.. (2004). Relationship between self reporting of past history of anti-tuberculosis treatment and radiographic findings in multidrug-resistant tuberculosis.. PubMed. 8(11). 1385–7.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Kogieleum Naidoo Breakdown of academic impact, for papers by Sayoki Mfinanga Breakdown of academic impact, for papers by Marcos Espinal Breakdown of academic impact, for papers by Neel R. Gandhi Breakdown of academic impact, for papers by Haileyesus Getahun Breakdown of academic impact, for papers by Francesca Conradie Breakdown of academic impact, for papers by Umesh Lalloo Breakdown of academic impact, for papers by Mercedes C. Becerra Breakdown of academic impact, for papers by Peter Mwaba Breakdown of academic impact, for papers by Anthony P. Moll